AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2020
Feb 11, 2020
33298_dirs_2020-02-10_310e002d-d43a-433d-be3e-fc4002d188ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-01-20
Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to purchase Common Stock | $0.23 | 2029-02-26 | Common Stock (200000) | Direct | |
| Option to purchase Common Stock | $0.23 | 2029-11-26 | Common Stock (200000) | Direct |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17